Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
134 STAT. 4915
PUBLIC LAW 116–304—JAN. 5, 2021
Public Law 116–304
116th Congress
An Act
To amend the Federal Food, Drug, and Cosmetic Act to give authority to the
Secretary of Health and Human Services, acting through the Commissioner of
Food and Drugs, to destroy counterfeit devices.
Be it enacted by the Senate and House of Representatives of
the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Safeguarding Therapeutics Act’’.
SEC. 2. AUTHORITY TO DESTROY COUNTERFEIT DEVICES.
(a) IN GENERAL.—Section 801(a) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 381(a)) is amended—
(1) in the fourth sentence, by inserting ‘‘or counterfeit
device’’ after ‘‘counterfeit drug’’; and
(2) by striking ‘‘The Secretary of the Treasury shall cause
the destruction of’’ and all that follows through ‘‘liable for
costs pursuant to subsection (c).’’ and inserting the following:
‘‘The Secretary of the Treasury shall cause the destruction
of any such article refused admission unless such article is
exported, under regulations prescribed by the Secretary of the
Treasury, within 90 days of the date of notice of such refusal
or within such additional time as may be permitted pursuant
to such regulations, except that the Secretary of Health and
Human Services may destroy, without the opportunity for
export, any drug or device refused admission under this section,
if such drug or device is valued at an amount that is $2,500
or less (or such higher amount as the Secretary of the Treasury
may set by regulation pursuant to section 498(a)(1) of the
Tariff Act of 1930 (19 U.S.C. 1498(a)(1))) and was not brought
into compliance as described under subsection (b). The Sec-
retary of Health and Human Services shall issue regulations
providing for notice and an opportunity to appear before the
Secretary of Health and Human Services and introduce testi-
mony, as described in the first sentence of this subsection,
on destruction of a drug or device under the seventh sentence
of this subsection. The regulations shall provide that prior
to destruction, appropriate due process is available to the owner
or consignee seeking to challenge the decision to destroy the
drug or device. Where the Secretary of Health and Human
Services provides notice and an opportunity to appear and
introduce testimony on the destruction of a drug or device,
the Secretary of Health and Human Services shall store and,
as applicable, dispose of the drug or device after the issuance
Regulations.
Regulations.
Deadline.
Notices.
21 USC 301 note.
Safeguarding
Therapeutics Act.
Jan. 5, 2021
[H.R. 5663]
VerDate Sep 11 2014
11:29 Jan 12, 2021
Jkt 019139
PO 00304
Frm 00001
Fmt 6580
Sfmt 6581
E:\PUBLAW\PUBL304.116
PUBL304
wwoods2 on LAPJF8D0R2PROD with PUBLAW
134 STAT. 4916
PUBLIC LAW 116–304—JAN. 5, 2021
LEGISLATIVE HISTORY—H.R. 5663:
HOUSE REPORTS: No. 116–512 (Comm. on Energy and Commerce).
CONGRESSIONAL RECORD, Vol. 166 (2020):
Sept. 21, considered and passed House.
Dec. 8, considered and passed Senate, amended.
Dec. 10, House concurred in Senate amendment.
Æ
of the notice, except that the owner and consignee shall remain
liable for costs pursuant to subsection (c).’’.
(b) DEFINITION.—Section 201(h) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C. 321(h)) is amended—
(1) by redesignating subparagraphs (1), (2), and (3) as
clauses (A), (B), and (C), respectively; and
(2) after making such redesignations—
(A) by striking ‘‘(h) The term’’ and inserting ‘‘(h)(1)
The term’’; and
(B) by adding at the end the following:
‘‘(2) The term ‘counterfeit device’ means a device which, or
the container, packaging, or labeling of which, without authoriza-
tion, bears a trademark, trade name, or other identifying mark
or imprint, or any likeness thereof, or is manufactured using a
design, of a device manufacturer, processor, packer, or distributor
other than the person or persons who in fact manufactured, proc-
essed, packed, or distributed such device and which thereby falsely
purports or is represented to be the product of, or to have been
packed or distributed by, such other device manufacturer, processor,
packer, or distributor.’’.
Approved January 5, 2021.
VerDate Sep 11 2014
11:29 Jan 12, 2021
Jkt 019139
PO 00304
Frm 00002
Fmt 6580
Sfmt 6580
E:\PUBLAW\PUBL304.116
PUBL304
wwoods2 on LAPJF8D0R2PROD with PUBLAW
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.